Estrogen Receptor and Vascular Aging

Area of Science:

• Cardiovascular Science
• Endocrinology
• Gerontology

Background:

• Cardiovascular diseases (CVDs) are age-related, with higher prevalence in men before menopause, a gap that narrows post-menopause.
• Estrogens exert a vasculoprotective role before menopause, but their decline's impact on cardiovascular risk during menopause is debated.
• Estrogen receptors (ERs), including ERα and ERβ, mediate the arterial actions of estrogens and androgens via nuclear and non-genomic pathways.

Purpose of the Study:

• To review clinical and experimental studies on estrogen's protective effects against CVDs, focusing on atherosclerosis.
• To examine the impact of aging and estrogen deprivation on endothelial actions of estrogens.
• To discuss how ERα mechanisms may optimize menopausal hormone therapy.

Main Methods:

• Review of clinical and experimental studies.
• Analysis of estrogen's effects on cardiovascular health and atherosclerosis.
• Investigation of estrogen receptor (ER) expression and function in arterial tissues.

Main Results:

• Estrogen deprivation at menopause is linked to increased cardiovascular risk.
• ERα and ERβ mediate estrogen's protective effects on arteries.
• Dysregulation of ER expression/function may impair estrogen's protective role in aging arteries.

Conclusions:

• Estrogen decline significantly impacts cardiovascular health post-menopause.
• Understanding ER mechanisms is key to addressing age-related cardiovascular risks in women.
• Novel insights into ERα action could refine menopausal hormone therapy strategies.